Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin)
Clinical trial NCT00955110 · COMPLETED
Trial details
- NCT number
- NCT00955110
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2009-09-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.